Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Recovery Following Partial Medial Meniscectomy

In brief

The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).

Key facts

Study ID

NCT00702741

Run by

Mesoblast International Sàrl

People needed

55

Starts

2008-06-01

Expected to finish

2011-09-01

Last updated by the study team

2022-01-11

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must have received an injection in Protocol No. 550
• Subject must have completed the 6-month and final 2-year visit in Protocol No. 550
• Subject must provide written informed consent for entry into the extension study
• Subject must provide authorization for use and disclosure of protected health information for entry into the extension study

Where it is running

• University of Southern California Keck School of Medicine — Los Angeles, California, United States
• OrthoIndy — Indianapolis, Indiana, United States
• TRIA Orthopaedic Center — Bloomington, Minnesota, United States
• Unlimited Research — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.